Govt expert panel accepts Covaxin Phase-3 trials data
Covaxin was developed with seed strains received from the National Institute of Virology and the Phase-3 clinical trials have been co-funded by the ICMR.The Drug Controller General of India (DCGI) on Tuesday accepted the 77.8% efficacy of…